Back to Trials
NCT06730555NARecruitingAccepts Healthy Volunteers

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

University of Miami

Start Date

6/27/2025

Completion Date

8/1/2028

Summary

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * SSPs must: 1. be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions; 2. serve at least 300 unique participants per year; 3. not currently offer opt-out HIV/HCV testing; 4. be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics; 5. have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study. Exclusion Criteria: * SSPs must not: 1. currently receive or have received Frontline Communities in the United States (FOCUS) funding; 2. have already implemented opt-out HIV/HCV testing. 3. currently participating in SAIA-SSP-HIV (NCT06025435)

Interventions

BEHAVIORAL

ACCESS Intervention

BEHAVIORAL

Control Group

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

HIV Infections

Locations

University of Miami

Miami, Florida 33136

United States